Status:
COMPLETED
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Use Disorders
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
The broad, long-term objective of the proposed randomized clinical trial is to evaluate the efficacy, moderators and mechanisms of change of two cognitive-behavioral aftercare treatments for alcohol a...
Detailed Description
Relapse to alcohol and other drug use (AOD) following treatment continues to be a costly problem for individual, society, and the substance abuse treatment community, and thus warrants the continued d...
Eligibility Criteria
Inclusion
- completion or scheduled completion (i.e., within 2 weeks) of Inpatient or Intensive Outpatient treatment
- fluency in English
- enrollment in a substance abuse aftercare program
- medical clearance by referring provider
- willingness to accept random assignment to treatment condition
Exclusion
- already participated in the pilot MBRP trial conducted by this research team
- participation in the comorbid disorders or relapse prevention groups offered at partner agency
- comorbid psychosis (including schizophrenia, schizoaffective or other schizophreniform disorder)and/or dementia, acute suicidality/intent to harm others, severe cognitive impairment, and high risk of withdrawal or medical complications stemming from relapse which would require a higher level of care.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
286 Patients enrolled
Trial Details
Trial ID
NCT01159535
Start Date
October 1 2009
End Date
July 1 2012
Last Update
August 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Recovery Centers of King County
Seattle, Washington, United States, 98122